Studies: Inocularly vaccinated those who take two doses to strengthen the needle to fi

(Connecticic) research shows that the inoculation of two doses of the Koxing vaccine with Pfizer enhanced needle, which is far better than the protection of other coronal virus strains.

According to Reuters, the study was conducted by researchers from Yale University, Dominica Health and other institutions. It has not been evaluated by colleagues.

Studies have shown that two -dose Koting vaccine with Pfizer's reinforced antibody levels are similar to the two doses of messengor nucleoscanic acid (mRNA) vaccine.

Two doses of Koting vaccine with Pfizer's antibody level to the original strain is 6.3 times higher than the level of Omikon's antibody level;2.7 times.

One of the authors of the research report said on Twitter that those who vaccinated the Kotox vaccine may need to take two doses to strengthen the needle to achieve the level of protection needed to fight the Omikon virus.

The study analyzed the plasma samples of 101 participants in Dominica.The study also shows that only two doses of Koting vaccine cannot detect any neutralization of Omikon.